Measurement of macrophage marker in hyperhaemolytic transfusion reaction: a case report

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Transfusion Medicine

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-3148.2011.01131.xPMID 22233101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum Neopterin Levels as a Diagnostic Marker of Hemophagocytic Lymphohistiocytosis Syndrome

  2011cited by this paper
• Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.

  2010cited by this paper
• Anti‐Fy3 in sickle cell disease: a difficult transfusion problem

  2009cited by this paper
• Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death

  2009cited by this paper
• Hyperhemolysis syndrome in sickle cell disease

  2009cited by this paper
• Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease

  2008cited by this paper
• Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review

  2008cited by this paper
• The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction?

  2008cited by this paper
• Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia

  2006cited by this paper
• Haemophagocytic syndromes in adults: current concepts and challenges ahead.

  2005cited by this paper
• Volume Index

  2005cited by this paper
• Hyperhemolysis syndrome in anemia of chronic disease

  2005cited by this paper
• Acute hemolytic transfusion reaction secondary to anti-Fy3

  2005cited by this paper
• Secretion of Ferritin by Iron-laden Macrophages and Influence of Lipoproteins

  2004cited by this paper
• Use of Intravenous Immunoglobulin and Intravenous Methylprednisolone in Hyperhaemolysis Syndrome in Sickle Cell Disease

  2004cited by this paper
• Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

  2003cited by this paper
• High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation.

  2003cited by this paper
• Cytoadherence of Malaria-Infected Red Blood Cells Involves Exposure of Phosphatidylserine

  2002cited by this paper
• Neopterin as a marker for immune system activation.

  2002cited by this paper
• Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

  2002cited by this paper
• Identification of the haemoglobin scavenger receptor

  2001cited by this paper
• Hyperhemolytic transfusion reaction in sickle cell disease

  2001cited by this paper
• A receptor for phosphatidylserine-specific clearance of apoptotic cells

  2000cited by this paper
• Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.

  2000cited by this paper
• Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia.

  1998cited by this paper
• Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells

  1997cited by this paper
• Severe reactions associated with transfusion of patients with sickle cell disease

  1997cited by this paper
• The sickle cell hemolytic transfusion reaction syndrome

  1997influential reference
• Monocyte phagocytic activity in sickle cell disease.

  1991cited by this paper
• Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.

  1990cited by this paper
• Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease

  1990cited by this paper
• Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia.

  1984cited by this paper
• The Duffy blood group system

  1950cited by this paper

• Influence of Acute Phase Proteins on Neutrophil Function In Vitro

  2025cites this paper
• Heme Scavenging and Delivery: The Role of Human Serum Albumin

  2023cites this paper
• Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far

  2022cites this paper
• Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab

  2021cites this paper
• American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

  2020cites this paper
• Hyperhemolytic Transfusion Reaction in Non-Hemoglobinopathy Patients and Terminal Complement Pathway Activation: Case Series and Review of the Literature.

  2020cites this paper
• Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab

  2020cites this paper
• Accelerated erythrocyte destruction mimicking post‐transfusion hyperhaemolysis in the course of uncomplicated vaso‐occlusive crisis associated with sickle cell disease

  2020cites this paper
• Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy

  2020cites this paper
• Histopathological evidence for macrophage activation driving post‐transfusion hyperhaemolysis syndrome

  2019cites this paper
• Hyperhaemolysis in a pregnant patient with HbH disease

  2019cites this paper
• Hyperhaemolysis Syndrome in Sickle Cell Disease

  2019influential citation
• Hyperhemolysis syndrome: theory and practice

  2018cites this paper
• Delayed haemolytic and serologic transfusion reactions: pathophysiology, treatment and prevention

  2018cites this paper
• Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects

  2017cites this paper
• Immunological complications of blood transfusions.

  2016cites this paper
• RED CELLS , IRON , AND ERYTHROPOIESIS Hemopexin therapy reverts heme-induced proin fl ammatory phenotypic switching of macrophages in a mouse model of sickle cell disease

  2016cites this paper
• Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.

  2016cites this paper
• Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab

  2015cites this paper
• Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature.

  2015cites this paper
• Hyperhaemolysis in a patient with chronic lymphocytic leukaemia

  2014cites this paper
• WHAT DO WE MEAN BY “HYPERHAEMOLYSIS” AND WHAT IS THE CAUSE?

  2012influential citation